View Item 

Show simple item record

Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation‐wide Cohort Study
dc.contributor.authorJepsen, Peter
dc.contributor.authorTapper, Elliot B.
dc.contributor.authorDeleuran, Thomas
dc.contributor.authorKazankov, Konstantin
dc.contributor.authorAskgaard, Gro
dc.contributor.authorSørensen, Henrik Toft
dc.contributor.authorVilstrup, Hendrik
dc.contributor.authorWest, Joe
dc.date.accessioned2021-11-02T00:44:52Z
dc.date.available2022-12-01 20:44:51en
dc.date.available2021-11-02T00:44:52Z
dc.date.issued2021-11
dc.identifier.citationJepsen, Peter; Tapper, Elliot B.; Deleuran, Thomas; Kazankov, Konstantin; Askgaard, Gro; Sørensen, Henrik Toft ; Vilstrup, Hendrik; West, Joe (2021). "Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation‐wide Cohort Study." Hepatology (5): 2725-2734.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/170797
dc.publisherWiley Periodicals, Inc.
dc.titleRisk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation‐wide Cohort Study
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/170797/1/hep32019-sup-0001-Supinfo.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/170797/2/hep32019.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/170797/3/hep32019_am.pdf
dc.identifier.doi10.1002/hep.32019
dc.identifier.sourceHepatology
dc.identifier.citedreferenceAlqahtani F, Balla S, AlHajji M, Chaudhary F, Albeiruti R, Kawsara A, et al. Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis. Catheter Cardiovasc Interv 2020; 96: 802 ‐ 810.
dc.identifier.citedreferenceKrarup LH, Boysen G, Janjua H, Prescott E, Truelsen T. Validity of stroke diagnoses in a national register of patients. Neuroepidemiology 2007; 28: 150 ‐ 154.
dc.identifier.citedreferenceDi Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016; 388: 3060 ‐ 3073.
dc.identifier.citedreferenceCampbell BCV, Khatri P. Stroke. Lancet 2020; 396: 129 ‐ 142.
dc.identifier.citedreferenceGo AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296 ‐ 1305.
dc.identifier.citedreferenceUnited Network for Organ Sharing. Clerical changes for implementation of adding serum sodium to the MELD score. https://optn.transplant.hrsa.gov/media/1575/policynotice_20151101.pdf. Published November 23, 2015. Accessed on April 8, 2020.
dc.identifier.citedreferenceValkhoff VE, Coloma PM, Masclee GM, Gini R, Innocenti F, Lapi F, et al. Validation study in four health‐care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug‐related upper gastrointestinal bleeding risk. J Clin Epidemiol 2014; 67: 921 ‐ 931.
dc.identifier.citedreferenceTripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, de Franchis R, et al. An imbalance of pro‐ vs anti‐coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009; 137: 2105 ‐ 2111.
dc.identifier.citedreferenceNery F, Chevret S, Condat B, de Raucourt E, Boudaoud L, Rautou PE, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology 2015; 61: 660 ‐ 667.
dc.identifier.citedreferenceLoffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta‐analysis. Gastroenterology 2017; 153: 480 ‐ 487.e1.
dc.identifier.citedreferencePottegård A, Schmidt SAJ, Wallach‐Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol 2017; 46: 798 ‐ 798f.
dc.identifier.citedreferenceParikh NS, Navi BB, Schneider Y, Jesudian A, Kamel H. Association between cirrhosis and stroke in a nationally representative cohort. JAMA Neurol 2017; 74: 927 ‐ 932.
dc.identifier.citedreferenceDam MK, Flensborg‐Madsen T, Eliasen M, Becker U, Tolstrup JS. Smoking and risk of liver cirrhosis: a population‐based cohort study. Scand J Gastroenterol 2013; 48: 585 ‐ 591.
dc.identifier.citedreferenceDanielsen KV, Wiese S, Hove J, Bendtsen F, Møller S. Pronounced coronary arteriosclerosis in cirrhosis: influence on cardiac function and survival? Dig Dis Sci 2018; 63: 1355 ‐ 1362.
dc.identifier.citedreferenceKrag A, Bendtsen F, Henriksen JH, Moller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010; 59: 105 ‐ 110.
dc.identifier.citedreferenceKrag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non‐haemodynamic effects of beta‐blockers improve survival of patients with cirrhosis during a window in the disease. Gut 2012; 61: 967 ‐ 969.
dc.identifier.citedreferenceDam Fialla A, Schaffalitzky de Muckadell OB, Touborg Lassen A. Incidence, etiology and mortality of cirrhosis: a population‐based cohort study. Scand J Gastroenterol 2012; 47: 702 ‐ 709.
dc.identifier.citedreferenceJepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population‐based cohort study. Hepatology 2010; 51: 1675 ‐ 1682.
dc.identifier.citedreferenceVestberg K, Thulstrup AM, Sørensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst 1997; 21: 11 ‐ 20.
dc.identifier.citedreferenceJepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark—population‐based incidence, prevalence, and hospitalization rates between 1988 and 2005: A descriptive cohort study. BMC Gastroenterol 2008; 8: 3.
dc.identifier.citedreferenceVilla E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143: 1253 ‐ 1260.e4.
dc.identifier.citedreferenceDhar A, Mullish BH, Thursz MR. Anticoagulation in chronic liver disease. J Hepatol 2017; 66: 1313 ‐ 1326.
dc.identifier.citedreferenceAli M, Ananthakrishnan AN, McGinley EL, Saeian K. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 2011; 56: 2152 ‐ 2159.
dc.identifier.citedreferenceAmbrosino P, Tarantino L, Di Minno G, Paternoster M, Graziano V, Petitto M, et al. The risk of venous thromboembolism in patients with cirrhosis: a systematic review and meta‐analysis. Thromb Haemost 2017; 117: 139 ‐ 148.
dc.identifier.citedreferenceVioli F, Ferro D. Clotting activation and hyperfibrinolysis in cirrhosis: Implication for bleeding and thrombosis. Semin Thromb Hemost 2013; 39: 426 ‐ 433.
dc.identifier.citedreferenceSøgaard KK, Adelborg K, Darvalics B, Horvath‐Puho E, Beyer‐Westendorf J, Ageno W, et al. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population‐based cohort study. Lancet Haematol 2018; 5: e441 ‐ e449.
dc.identifier.citedreferenceSøgaard KK, Horvath‐Puho E, Grønbæk H, Jepsen P, Vilstrup H, Sørensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population‐based case‐control study. Am J Gastroenterol 2009; 104: 96 ‐ 101.
dc.identifier.citedreferenceNorthup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 2013; 11: 1064 ‐ 1074.
dc.identifier.citedreferenceTripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365: 147 ‐ 156.
dc.identifier.citedreferenceKazankov K, Munk K, Øvrehus KA, Jensen JM, Siggaard CB, Grønbæk H, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Invest 2017; 47: 565 ‐ 573.
dc.identifier.citedreferenceDeleuran T, Schmidt M, Vilstrup H, Jepsen P. Time‐dependent incidence and risk for myocardial infarction in patients with alcoholic cirrhosis. Eur J Clin Invest 2020; 50: e13205.
dc.identifier.citedreferenceZheng K, Yoshida EM, Tacke F, Li Y, Guo X, Qi X. Risk of stroke in liver cirrhosis: a systematic review and meta‐analysis. J Clin Gastroenterol 2020; 54: 96 ‐ 105.
dc.identifier.citedreferenceHillerson D, Ogunbayo GO, Salih M, Misumida N, Abdel‐Latif A, Smyth SS, et al. Outcomes and characteristics of myocardial infarction in patients with cirrhosis. J Invasive Cardiol 2019; 31: E162 ‐ E169.
dc.identifier.citedreferenceSøgaard KK, Horvath‐Puho E, Montomoli J, Vilstrup H, Sørensen HT. Cirrhosis is associated with an increased 30‐day mortality after venous thromboembolism. Clin Transl Gastroenterol 2015; 6: e97.
dc.identifier.citedreferenceSchmidt M, Horvath‐Puho E, Ording AG, Bøtker HE, Lash TL, Sørensen HT. The interaction effect of cardiac and non‐cardiac comorbidity on myocardial infarction mortality: a nationwide cohort study. Int J Cardiol 2020; 308: 1 ‐ 8.
dc.identifier.citedreferenceJepsen P, Vilstrup H, Andersen PK, Lash TL, Sørensen HT. Comorbidity and survival of Danish cirrhosis patients: a nationwide population‐based cohort study. Hepatology 2008; 48: 214 ‐ 220.
dc.identifier.citedreferenceSchmidt M, Schmidt SAJ, Adelborg K, Sundbøll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from healthcare contacts to database records. Clin Epidemiol 2019; 11: 563 ‐ 591.
dc.identifier.citedreferenceSchmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449 ‐ 490.
dc.identifier.citedreferenceArendt JFH, Hansen AT, Ladefoged SA, Sørensen HT, Pedersen L, Adelborg K. Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol 2020; 12: 469 ‐ 475.
dc.identifier.citedreferenceSchmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014; 29: 541 ‐ 549.
dc.identifier.citedreferenceSundbøll J, Adelborg K, Munch T, Frøslev T, Sørensen HT, Bøtker HE, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 2016; 6: e012832.
dc.identifier.citedreferenceJohnsen SP, Overvad K, Sørensen HT, Tjønneland A, Husted SE. Predictive value of stroke and transient ischemic attack discharge diagnoses in the Danish National Registry of Patients. J Clin Epidemiol 2002; 55: 602 ‐ 607.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep32019-sup-0001-Supinfo.pdf
Size:
62.07KB
Format:
PDF
View/Open
Name:
hep32019.pdf
Size:
224.9KB
Format:
PDF
View/Open
Name:
hep32019_am.pdf
Size:
243.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.